Home > Insider Trading > Filing (0001179110-20-007780)

Filing Details

Accession Number:: 0001179110-20-007780
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-06-25 18:22:18
Reporting Period:: 2020-06-23

Accepted Time:: 2020-06-25 18:22:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1697362	Burkes Michael Brophy	C/O Natera, Inc., 201 Industrial Road Suite 410 San Carlos CA 94070	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-06-23	12,500	$0.00	54,166	No	4	M	Direct
Common Stock	Disposition	2020-06-24	5,049	$45.47	49,117	No	4	S	Direct
Common Stock	Disposition	2020-06-24	4,572	$46.02	44,545	No	4	S	Direct
Common Stock	Disposition	2020-06-24	400	$46.64	44,145	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2029-06-23	12,500	$0.00	12,500	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
37,500			No	4	M	Direct

Footnotes

Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting September 19, 2019.
Each RSU represents a contingent right to receive one share of the common stock of the issuer.
The sale of shares was effected in order to satisfy tax liabilities due at the time of vesting.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.47 to $45.4975 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2019.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.47 to $46.44 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
On March 22, 2019, the Reporting Person was granted RSUs covering 100,000 shares of common stock, which vests in tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. On June 23, 2020, the criteria was satisfied for the vesting of RSUs covering 12,500 shares of common stock.